Psychiatry News

College students who identified as transgender or gender nonconforming and those with autism had a greater risk for suicidal thoughts and behaviors, study results published in JAMA Network Open showed.

The world is facing an impending tsunami as the number of people developing Alzheimer’s disease continues to grow.

Positive screenings for autism spectrum disorders did not increase to a significant degree among children born during the COVID-19 pandemic, according to results of a cohort study published in JAMA Network Open.

FDA black box warnings about antidepressants for pediatric patients — meant to decrease suicidal thoughts and behavior — may have had the opposite effect, according to a systematic review.

Adults with a schizophrenia spectrum disorder had increased risk for severe infection outcomes while exposed to antipsychotics compared with nonexposure periods, according to a study published in The Lancet Psychiatry.

Higher doses of buprenorphine were associated with significantly lower rates of acute care utilization among adults with opioid use disorder compared with the FDA’s recommended dose, according to a study published in JAMA Network Open.

Patients with chronic pain showed greater support for several policies expanding access to cannabis compared with physicians, a research letter in JAMA Network Open showed.

Fatal and nonfatal drug overdoses experienced “unprecedented” decreases of 10% to 20% from last year, which could be due to factors like increased naloxone availability, according to researchers.

SAN DIEGO — Improving depressive symptoms can reduce patients’ chronic pain, according to a presenter at the 2024 Congress of Clinical Rheumatology West.

Obscured by the celebratory congratulations and profuse praise of the scientific advance marked by the FDA’s approval of KarXT, now branded Cobenfy, is the revealing and instructive story of how this novel therapeutic agent came to fruition.